Clinical Trial Update: Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia [Phase 2]

View source ↗

Summary

Telitacicept is being studied in a Phase 2 trial for thrombocytopenia associated with connective tissue diseases. The study is currently recruiting and sponsore…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Connective Tissue Diseases
• Thrombocytopenia

Drugs mentioned

• Telitacicept

Snippet

Sponsor: Beijing Hospital | Conditions: Connective Tissue Diseases, Thrombocytopenia | Phase 2 | Status: RECRUITING